Shweta Munjal, formerly with Lupin, has now joined generic and branded drugs major Glenmark Pharmaceuticals as chief, of communications and CSR. Munjal was previously, VP & global head - brand, corporate marketing and communications & sustainability at Lupin.
Earlier this week, Glenmark received USFDA approval for Acetaminophen and Ibuprofen tablets of 250 mg/125 mg (OTC). According to media reports, "Glenmark’s portfolio consists of 195 products authorized for distribution in the U.S. marketplace."
Munjal has over 20 years of experience in corporate communications and was the first person to join the corporate communications team for Yahoo! India. She went on to work with Thomson Reuters, Intuit, Mondelez and Lupin.
If you enjoyed this article, you can subscribe for free to our weekly event and subscriber alerts.
We have four email alerts in total - covering ESG, PR news, events and awards. Enter your email address below to find out more: